MUMBAI – Three private equity firms are planning to sell stakes worth Rs 3,000-4,000 crore in Mankind Pharma through block deals on Tuesday, according to news reports.
Chrys Capital, Capital Group and Everbridge Partners are looking to sell 5-6% stake in the pharmaceutical major.
Kotak Mahindra Capital is one of the advisors to the deal, and the private equity investors are offering a discount of upto 7% from the current price. The floor price has been set at Rs 1,785.65 a share. On Monday, shares of the drug major nearly 2% down at Rs 1,918.75 on the BSE.
Mankind Pharma shares have gained a sharp 30% in the last six months. In May, the stock made its debut on the bourses, and the company’s IPO was one of the biggest in the pharmaceutical sector after Gland Pharma’s in 2020.
